Key Points
- Oscar Health CFO Richard Scott Blackley sold 100,000 shares on May 14 at an average price of $23.16, generating $2.316 million in proceeds. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and he still held 1.22 million shares afterward.
- Shares of Oscar Health were trading higher, opening at $25.37 and rising 8.8% in the session described. The stock has moved within a 52-week range of $10.69 to $25.58 and has a market cap of about $7.65 billion.
- The company posted strong quarterly earnings growth, reporting $2.07 EPS versus the $1.11 consensus estimate, while revenue rose 52.6% year over year to $4.65 billion. Despite the beat, analysts currently have an average rating of “Hold” with a $18.22 price target.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CFO Richard Scott Blackley sold 100,000 shares of Oscar Health stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the sale, the chief financial officer directly owned 1,216,660 shares of the company's stock, valued at approximately $28,177,845.60. The trade was a 7.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Oscar Health Trading Up 8.8%
Shares of NYSE:OSCR opened at $25.37 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $25.58. The company has a market cap of $7.65 billion, a P/E ratio of -43.01, a PEG ratio of 1.63 and a beta of 2.34. The stock's fifty day moving average price is $15.73 and its 200-day moving average price is $15.44.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.Oscar Health's revenue was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.92 EPS. Sell-side analysts expect that Oscar Health, Inc. will post 0.47 earnings per share for the current year.
Hedge Funds Weigh In On Oscar Health
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Baird Financial Group Inc. bought a new position in shares of Oscar Health during the 1st quarter valued at approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company's stock worth $2,827,000 after acquiring an additional 8,879 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Oscar Health by 39.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company's stock valued at $6,169,000 after purchasing an additional 132,149 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts have commented on OSCR shares. Wall Street Zen raised shares of Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Saturday, May 9th. Zacks Research upgraded Oscar Health from a "hold" rating to a "strong-buy" rating in a research note on Thursday, May 7th. UBS Group upped their price objective on Oscar Health from $15.00 to $20.00 and gave the company a "neutral" rating in a research report on Thursday, May 7th. Raymond James Financial raised Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 target price on the stock in a report on Thursday, February 12th. Finally, Wolfe Research assumed coverage on Oscar Health in a research note on Tuesday, May 5th. They set a "peer perform" rating for the company. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $18.22.
Check Out Our Latest Stock Report on Oscar Health
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
